p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3
Author: ["Michele Makos Wales","Margaret A. Biel","Wafik El Deiry","Barry D. Nelkin","Jean-Pierre Issa","Webster K. Cavenee","Steven J. Kuerbitz","Stephen B. Baylin"]
Publication: Nature Medicine
CITE.CC academic search helps you expand the influence of your papers.
Abstract
For several human tumour types, allelic toss data suggest that one or more tumour suppressor genes reside telomeric to the p53 gene at chromosome 17p13.1. In the present study we have used a new strategy, involving molecular analysis of a DNA site hypermethylated in tumour DNA, to identify a candidate gene in this region (17p13.3). Our approach has led to identification of HIC-1 (hypermethylated in cancer), a new zinc-finger transcription factor gene which is ubiquitously expressed in normal tissues, but underexpressed in different tumour cells where it is hypermethylated. Multiple characteristics of this gene, including the presence of a p53 binding site in the 5′ flanking region, activation of the gene by expression of a wild-type p53 gene and suppression of C418 selectability of cultured brain, breast and colon cancer cells following insertion of the gene, make HIC-1 gene a strong candidate for a tumour suppressor gene in region 17p13.3.
Cite this article
Wales, M., Biel, M., Deiry, W. et al. p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nat Med 1, 570–577 (1995). https://doi.org/10.1038/nm0695-570
